Shaping the industry

PSI works to shape the industry by promoting good practice for pharmaceutical statisticians in the scientific literature [1, 2], by promoting the value of statistical insight in the development of medicines with our directory of consultants and by lobbying to increase statistical input in regulatory decisions [3].


Our regulatory committee reviews and comments on regulatory guidelines on behalf of industry statisticians. Our special interest groups and working parties are forums for statisticians to share experiences and form guidelines for good practice in their specific areas of expertise.

PSI is a member of EFSPI, the European federation of national pharmaceutical statistics bodies and participates through EFSPI in Europe-wide industry discussions.

If you wish to contribute to any of these activities, contact

Latest News

Show all news

EventsFuture Events

  • Webinar: MCP-Mod – Theory, Implementation and Extensions - Dates: 08 – 08 May, 2019

    MCP-Mod (Multiple Comparisons & Modelling) is a popular statistical methodology for model-based design and analysis of dose finding studies. This webinar will describe the theory behind MCP-Mod (plus extensions), and how to implement it within available software. Pantelis Vlachos (Cytel) will provide a brief introduction to the methodology and illustrate the MCP-MoD capabilities in EAST 6.5. Saswati Saha (University of Brehem) will discuss new variations and alternatives to MCP-Mod and show how to implement them in R. Neal Thomas (Pfizer) will present further technical details of MCP-Mod by evaluating the method using results from least squares linear model theory.
  • PSI Webinar: Statistical Engagement with Commercial Activities - Dates: 12 – 12 Mar, 2019


Principal Statistician